EDGAR Filing Documents for 0000891293-20-000012

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0000891293-20-000012

Filing Date

2020-03-13

Accepted

2020-03-12 20:24:08

Documents

Period of Report

2019-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-K	cti10k12312019document.htm	10-K	1702569
2	EXHIBIT 4.6	a2019exhibit46descriptiono.htm	EX-4.6	9409
3	EXHIBIT 10.46	a2019exhibit1046directorco.htm	EX-10.46	18529
4	EXHIBIT 21.1	a2019exhibit211subsidiaries.htm	EX-21.1	1621
5	EXHIBIT 23.1	a2019exhibit231accountingf.htm	EX-23.1	20177
6	EXHIBIT 31.1	a2019exhibit311sect302cert.htm	EX-31.1	9434
7	EXHIBIT 31.2	a2019exhibit312sect302cert.htm	EX-31.2	9685
8	EXHIBIT 32	a2019exhibit32sect906certc.htm	EX-32	9895
15		pipleline.jpg	GRAPHIC	46516
	Complete submission text file	0000891293-20-000012.txt		8358445

Data Files

Seq	Description	Document	Type	Size
9	XBRL INSTANCE DOCUMENT	ctic-20191231.xml	EX-101.INS	1428458
10	XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT	ctic-20191231.xsd	EX-101.SCH	66581
11	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT	ctic-20191231_cal.xml	EX-101.CAL	129299
12	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT	ctic-20191231_def.xml	EX-101.DEF	356646
13	XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT	ctic-20191231_lab.xml	EX-101.LAB	919319
14	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT	ctic-20191231_pre.xml	EX-101.PRE	556668

Mailing Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121

Business Address 3101 WESTERN AVENUE SUITE 800 SEATTLE WA 98121 2062827100

CTI BIOPHARMA CORP (Filer) CIK: 0000891293 (see all company filings)